Coherus BioSciences (CHRS)
(Delayed Data from NSDQ)
$1.90 USD
-0.22 (-10.38%)
Updated May 10, 2024 04:00 PM ET
After-Market: $1.90 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2024
Time: -- |
6/2024 | $-0.04 | 0.00% |
Earnings Summary
For their last quarter, Coherus BioSciences (CHRS) reported earnings of -$0.32 per share, missing the Zacks Consensus Estimate of -$0.05 per share. This reflects a negative earnings surprise of 540.00%. Look out for CHRS's next earnings release expected on August 07, 2024. For the next earning release, we expect the company to report earnings of -$0.04 per share, reflecting a year-over-year increase of 89.47%.
Earnings History
Price & Consensus
Zacks News for CHRS
Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates
CHRS: What are Zacks experts saying now?
Zacks Private Portfolio Services